Medical Care

Global Self-administered Biologics Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Self-administered Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-administered Biologics.
The Self-administered Biologics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Self-administered Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, by Delivery Device Type and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-administered Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
United Laboratory
Biocon
GSK
Bristol-Myers Squibb
Ganlee
Julphar Diabetes
Wockhardt
Viatris
BD
Johnson & Johnson
Amgen
Biogen Idec
Bayer
Pfizer
Roche
AbbVie
Takeda Pharmaceutical
Segment by Type
Insulin
GLP-1 Receptor Agonists
rhGH
Subcutaneous mAbs
Other
Segment by Delivery Device Type
Pre-filled syringe pens
Auto-injectors
Wearable infusion devices
Others
Segment by Technological Characteristics
Conventional Liquid Formulations
Sustained/Extended-release Biologics
Lyophilized Ready-to-use Formulations
Segment by Application
Diabetes
Rheumatoid Arthritis
Anaphylaxis
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Delivery Device Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Self-administered Biologics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Self-administered Biologics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Insulin
1.2.3 GLP-1 Receptor Agonists
1.2.4 rhGH
1.2.5 Subcutaneous mAbs
1.2.6 Other
1.3 Market by Delivery Device Type
1.3.1 Global Self-administered Biologics Market Size Growth Rate by Delivery Device Type: 2020 VS 2024 VS 2031
1.3.2 Pre-filled syringe pens
1.3.3 Auto-injectors
1.3.4 Wearable infusion devices
1.3.5 Others
1.4 Market by Technological Characteristics
1.4.1 Global Self-administered Biologics Market Size Growth Rate by Technological Characteristics: 2020 VS 2024 VS 2031
1.4.2 Conventional Liquid Formulations
1.4.3 Sustained/Extended-release Biologics
1.4.4 Lyophilized Ready-to-use Formulations
1.5 Market by Application
1.5.1 Global Self-administered Biologics Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Diabetes
1.5.3 Rheumatoid Arthritis
1.5.4 Anaphylaxis
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Self-administered Biologics Market Perspective (2020-2031)
2.2 Global Self-administered Biologics Growth Trends by Region
2.2.1 Global Self-administered Biologics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Self-administered Biologics Historic Market Size by Region (2020-2025)
2.2.3 Self-administered Biologics Forecasted Market Size by Region (2026-2031)
2.3 Self-administered Biologics Market Dynamics
2.3.1 Self-administered Biologics Industry Trends
2.3.2 Self-administered Biologics Market Drivers
2.3.3 Self-administered Biologics Market Challenges
2.3.4 Self-administered Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Self-administered Biologics Players by Revenue
3.1.1 Global Top Self-administered Biologics Players by Revenue (2020-2025)
3.1.2 Global Self-administered Biologics Revenue Market Share by Players (2020-2025)
3.2 Global Top Self-administered Biologics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Self-administered Biologics Revenue
3.4 Global Self-administered Biologics Market Concentration Ratio
3.4.1 Global Self-administered Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Self-administered Biologics Revenue in 2024
3.5 Global Key Players of Self-administered Biologics Head office and Area Served
3.6 Global Key Players of Self-administered Biologics, Product and Application
3.7 Global Key Players of Self-administered Biologics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Self-administered Biologics Breakdown Data by Type
4.1 Global Self-administered Biologics Historic Market Size by Type (2020-2025)
4.2 Global Self-administered Biologics Forecasted Market Size by Type (2026-2031)
5 Self-administered Biologics Breakdown Data by Application
5.1 Global Self-administered Biologics Historic Market Size by Application (2020-2025)
5.2 Global Self-administered Biologics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Self-administered Biologics Market Size (2020-2031)
6.2 North America Self-administered Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Self-administered Biologics Market Size by Country (2020-2025)
6.4 North America Self-administered Biologics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Self-administered Biologics Market Size (2020-2031)
7.2 Europe Self-administered Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Self-administered Biologics Market Size by Country (2020-2025)
7.4 Europe Self-administered Biologics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Self-administered Biologics Market Size (2020-2031)
8.2 Asia-Pacific Self-administered Biologics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Self-administered Biologics Market Size by Region (2020-2025)
8.4 Asia-Pacific Self-administered Biologics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Self-administered Biologics Market Size (2020-2031)
9.2 Latin America Self-administered Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Self-administered Biologics Market Size by Country (2020-2025)
9.4 Latin America Self-administered Biologics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Self-administered Biologics Market Size (2020-2031)
10.2 Middle East & Africa Self-administered Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Self-administered Biologics Market Size by Country (2020-2025)
10.4 Middle East & Africa Self-administered Biologics Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Self-administered Biologics Introduction
11.1.4 Novo Nordisk Revenue in Self-administered Biologics Business (2020-2025)
11.1.5 Novo Nordisk Recent Development
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Details
11.2.2 Sanofi-Aventis Business Overview
11.2.3 Sanofi-Aventis Self-administered Biologics Introduction
11.2.4 Sanofi-Aventis Revenue in Self-administered Biologics Business (2020-2025)
11.2.5 Sanofi-Aventis Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Self-administered Biologics Introduction
11.3.4 Eli Lilly Revenue in Self-administered Biologics Business (2020-2025)
11.3.5 Eli Lilly Recent Development
11.4 Tonghua Dongbao
11.4.1 Tonghua Dongbao Company Details
11.4.2 Tonghua Dongbao Business Overview
11.4.3 Tonghua Dongbao Self-administered Biologics Introduction
11.4.4 Tonghua Dongbao Revenue in Self-administered Biologics Business (2020-2025)
11.4.5 Tonghua Dongbao Recent Development
11.5 United Laboratory
11.5.1 United Laboratory Company Details
11.5.2 United Laboratory Business Overview
11.5.3 United Laboratory Self-administered Biologics Introduction
11.5.4 United Laboratory Revenue in Self-administered Biologics Business (2020-2025)
11.5.5 United Laboratory Recent Development
11.6 Biocon
11.6.1 Biocon Company Details
11.6.2 Biocon Business Overview
11.6.3 Biocon Self-administered Biologics Introduction
11.6.4 Biocon Revenue in Self-administered Biologics Business (2020-2025)
11.6.5 Biocon Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Self-administered Biologics Introduction
11.7.4 GSK Revenue in Self-administered Biologics Business (2020-2025)
11.7.5 GSK Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Self-administered Biologics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Self-administered Biologics Business (2020-2025)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Ganlee
11.9.1 Ganlee Company Details
11.9.2 Ganlee Business Overview
11.9.3 Ganlee Self-administered Biologics Introduction
11.9.4 Ganlee Revenue in Self-administered Biologics Business (2020-2025)
11.9.5 Ganlee Recent Development
11.10 Julphar Diabetes
11.10.1 Julphar Diabetes Company Details
11.10.2 Julphar Diabetes Business Overview
11.10.3 Julphar Diabetes Self-administered Biologics Introduction
11.10.4 Julphar Diabetes Revenue in Self-administered Biologics Business (2020-2025)
11.10.5 Julphar Diabetes Recent Development
11.11 Wockhardt
11.11.1 Wockhardt Company Details
11.11.2 Wockhardt Business Overview
11.11.3 Wockhardt Self-administered Biologics Introduction
11.11.4 Wockhardt Revenue in Self-administered Biologics Business (2020-2025)
11.11.5 Wockhardt Recent Development
11.12 Viatris
11.12.1 Viatris Company Details
11.12.2 Viatris Business Overview
11.12.3 Viatris Self-administered Biologics Introduction
11.12.4 Viatris Revenue in Self-administered Biologics Business (2020-2025)
11.12.5 Viatris Recent Development
11.13 BD
11.13.1 BD Company Details
11.13.2 BD Business Overview
11.13.3 BD Self-administered Biologics Introduction
11.13.4 BD Revenue in Self-administered Biologics Business (2020-2025)
11.13.5 BD Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Self-administered Biologics Introduction
11.14.4 Johnson & Johnson Revenue in Self-administered Biologics Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Self-administered Biologics Introduction
11.15.4 Amgen Revenue in Self-administered Biologics Business (2020-2025)
11.15.5 Amgen Recent Development
11.16 Biogen Idec
11.16.1 Biogen Idec Company Details
11.16.2 Biogen Idec Business Overview
11.16.3 Biogen Idec Self-administered Biologics Introduction
11.16.4 Biogen Idec Revenue in Self-administered Biologics Business (2020-2025)
11.16.5 Biogen Idec Recent Development
11.17 Bayer
11.17.1 Bayer Company Details
11.17.2 Bayer Business Overview
11.17.3 Bayer Self-administered Biologics Introduction
11.17.4 Bayer Revenue in Self-administered Biologics Business (2020-2025)
11.17.5 Bayer Recent Development
11.18 Pfizer
11.18.1 Pfizer Company Details
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Self-administered Biologics Introduction
11.18.4 Pfizer Revenue in Self-administered Biologics Business (2020-2025)
11.18.5 Pfizer Recent Development
11.19 Roche
11.19.1 Roche Company Details
11.19.2 Roche Business Overview
11.19.3 Roche Self-administered Biologics Introduction
11.19.4 Roche Revenue in Self-administered Biologics Business (2020-2025)
11.19.5 Roche Recent Development
11.20 AbbVie
11.20.1 AbbVie Company Details
11.20.2 AbbVie Business Overview
11.20.3 AbbVie Self-administered Biologics Introduction
11.20.4 AbbVie Revenue in Self-administered Biologics Business (2020-2025)
11.20.5 AbbVie Recent Development
11.21 Takeda Pharmaceutical
11.21.1 Takeda Pharmaceutical Company Details
11.21.2 Takeda Pharmaceutical Business Overview
11.21.3 Takeda Pharmaceutical Self-administered Biologics Introduction
11.21.4 Takeda Pharmaceutical Revenue in Self-administered Biologics Business (2020-2025)
11.21.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Self-administered Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Insulin
Table 3. Key Players of GLP-1 Receptor Agonists
Table 4. Key Players of rhGH
Table 5. Key Players of Subcutaneous mAbs
Table 6. Key Players of Other
Table 7. Global Self-administered Biologics Market Size Growth Rate by Delivery Device Type (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of Pre-filled syringe pens
Table 9. Key Players of Auto-injectors
Table 10. Key Players of Wearable infusion devices
Table 11. Key Players of Others
Table 12. Global Self-administered Biologics Market Size Growth Rate by Technological Characteristics (US$ Million): 2020 VS 2024 VS 2031
Table 13. Key Players of Conventional Liquid Formulations
Table 14. Key Players of Sustained/Extended-release Biologics
Table 15. Key Players of Lyophilized Ready-to-use Formulations
Table 16. Global Self-administered Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Self-administered Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Self-administered Biologics Market Size by Region (2020-2025) & (US$ Million)
Table 19. Global Self-administered Biologics Market Share by Region (2020-2025)
Table 20. Global Self-administered Biologics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 21. Global Self-administered Biologics Market Share by Region (2026-2031)
Table 22. Self-administered Biologics Market Trends
Table 23. Self-administered Biologics Market Drivers
Table 24. Self-administered Biologics Market Challenges
Table 25. Self-administered Biologics Market Restraints
Table 26. Global Self-administered Biologics Revenue by Players (2020-2025) & (US$ Million)
Table 27. Global Self-administered Biologics Market Share by Players (2020-2025)
Table 28. Global Top Self-administered Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-administered Biologics as of 2024)
Table 29. Ranking of Global Top Self-administered Biologics Companies by Revenue (US$ Million) in 2024
Table 30. Global 5 Largest Players Market Share by Self-administered Biologics Revenue (CR5 and HHI) & (2020-2025)
Table 31. Global Key Players of Self-administered Biologics, Headquarters and Area Served
Table 32. Global Key Players of Self-administered Biologics, Product and Application
Table 33. Global Key Players of Self-administered Biologics, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Self-administered Biologics Market Size by Type (2020-2025) & (US$ Million)
Table 36. Global Self-administered Biologics Revenue Market Share by Type (2020-2025)
Table 37. Global Self-administered Biologics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 38. Global Self-administered Biologics Revenue Market Share by Type (2026-2031)
Table 39. Global Self-administered Biologics Market Size by Application (2020-2025) & (US$ Million)
Table 40. Global Self-administered Biologics Revenue Market Share by Application (2020-2025)
Table 41. Global Self-administered Biologics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 42. Global Self-administered Biologics Revenue Market Share by Application (2026-2031)
Table 43. North America Self-administered Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. North America Self-administered Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 45. North America Self-administered Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Europe Self-administered Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Europe Self-administered Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Europe Self-administered Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Self-administered Biologics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 50. Asia-Pacific Self-administered Biologics Market Size by Region (2020-2025) & (US$ Million)
Table 51. Asia-Pacific Self-administered Biologics Market Size by Region (2026-2031) & (US$ Million)
Table 52. Latin America Self-administered Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Latin America Self-administered Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 54. Latin America Self-administered Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 55. Middle East & Africa Self-administered Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 56. Middle East & Africa Self-administered Biologics Market Size by Country (2020-2025) & (US$ Million)
Table 57. Middle East & Africa Self-administered Biologics Market Size by Country (2026-2031) & (US$ Million)
Table 58. Novo Nordisk Company Details
Table 59. Novo Nordisk Business Overview
Table 60. Novo Nordisk Self-administered Biologics Product
Table 61. Novo Nordisk Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 62. Novo Nordisk Recent Development
Table 63. Sanofi-Aventis Company Details
Table 64. Sanofi-Aventis Business Overview
Table 65. Sanofi-Aventis Self-administered Biologics Product
Table 66. Sanofi-Aventis Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 67. Sanofi-Aventis Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Self-administered Biologics Product
Table 71. Eli Lilly Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. Tonghua Dongbao Company Details
Table 74. Tonghua Dongbao Business Overview
Table 75. Tonghua Dongbao Self-administered Biologics Product
Table 76. Tonghua Dongbao Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 77. Tonghua Dongbao Recent Development
Table 78. United Laboratory Company Details
Table 79. United Laboratory Business Overview
Table 80. United Laboratory Self-administered Biologics Product
Table 81. United Laboratory Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 82. United Laboratory Recent Development
Table 83. Biocon Company Details
Table 84. Biocon Business Overview
Table 85. Biocon Self-administered Biologics Product
Table 86. Biocon Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 87. Biocon Recent Development
Table 88. GSK Company Details
Table 89. GSK Business Overview
Table 90. GSK Self-administered Biologics Product
Table 91. GSK Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 92. GSK Recent Development
Table 93. Bristol-Myers Squibb Company Details
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Self-administered Biologics Product
Table 96. Bristol-Myers Squibb Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 97. Bristol-Myers Squibb Recent Development
Table 98. Ganlee Company Details
Table 99. Ganlee Business Overview
Table 100. Ganlee Self-administered Biologics Product
Table 101. Ganlee Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 102. Ganlee Recent Development
Table 103. Julphar Diabetes Company Details
Table 104. Julphar Diabetes Business Overview
Table 105. Julphar Diabetes Self-administered Biologics Product
Table 106. Julphar Diabetes Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 107. Julphar Diabetes Recent Development
Table 108. Wockhardt Company Details
Table 109. Wockhardt Business Overview
Table 110. Wockhardt Self-administered Biologics Product
Table 111. Wockhardt Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 112. Wockhardt Recent Development
Table 113. Viatris Company Details
Table 114. Viatris Business Overview
Table 115. Viatris Self-administered Biologics Product
Table 116. Viatris Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 117. Viatris Recent Development
Table 118. BD Company Details
Table 119. BD Business Overview
Table 120. BD Self-administered Biologics Product
Table 121. BD Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 122. BD Recent Development
Table 123. Johnson & Johnson Company Details
Table 124. Johnson & Johnson Business Overview
Table 125. Johnson & Johnson Self-administered Biologics Product
Table 126. Johnson & Johnson Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 127. Johnson & Johnson Recent Development
Table 128. Amgen Company Details
Table 129. Amgen Business Overview
Table 130. Amgen Self-administered Biologics Product
Table 131. Amgen Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 132. Amgen Recent Development
Table 133. Biogen Idec Company Details
Table 134. Biogen Idec Business Overview
Table 135. Biogen Idec Self-administered Biologics Product
Table 136. Biogen Idec Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 137. Biogen Idec Recent Development
Table 138. Bayer Company Details
Table 139. Bayer Business Overview
Table 140. Bayer Self-administered Biologics Product
Table 141. Bayer Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 142. Bayer Recent Development
Table 143. Pfizer Company Details
Table 144. Pfizer Business Overview
Table 145. Pfizer Self-administered Biologics Product
Table 146. Pfizer Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 147. Pfizer Recent Development
Table 148. Roche Company Details
Table 149. Roche Business Overview
Table 150. Roche Self-administered Biologics Product
Table 151. Roche Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 152. Roche Recent Development
Table 153. AbbVie Company Details
Table 154. AbbVie Business Overview
Table 155. AbbVie Self-administered Biologics Product
Table 156. AbbVie Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 157. AbbVie Recent Development
Table 158. Takeda Pharmaceutical Company Details
Table 159. Takeda Pharmaceutical Business Overview
Table 160. Takeda Pharmaceutical Self-administered Biologics Product
Table 161. Takeda Pharmaceutical Revenue in Self-administered Biologics Business (2020-2025) & (US$ Million)
Table 162. Takeda Pharmaceutical Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report


List of Figures
Figure 1. Self-administered Biologics Picture
Figure 2. Global Self-administered Biologics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Self-administered Biologics Market Share by Type: 2024 VS 2031
Figure 4. Insulin Features
Figure 5. GLP-1 Receptor Agonists Features
Figure 6. rhGH Features
Figure 7. Subcutaneous mAbs Features
Figure 8. Other Features
Figure 9. Global Self-administered Biologics Market Size Comparison by Delivery Device Type (2020-2031) & (US$ Million)
Figure 10. Pre-filled syringe pens Features
Figure 11. Auto-injectors Features
Figure 12. Wearable infusion devices Features
Figure 13. Others Features
Figure 14. Global Self-administered Biologics Market Size Comparison by Technological Characteristics (2020-2031) & (US$ Million)
Figure 15. Conventional Liquid Formulations Features
Figure 16. Sustained/Extended-release Biologics Features
Figure 17. Lyophilized Ready-to-use Formulations Features
Figure 18. Global Self-administered Biologics Market Size by Application (2020-2031) & (US$ Million)
Figure 19. Global Self-administered Biologics Market Share by Application: 2024 VS 2031
Figure 20. Diabetes Case Studies
Figure 21. Rheumatoid Arthritis Case Studies
Figure 22. Anaphylaxis Case Studies
Figure 23. Others Case Studies
Figure 24. Self-administered Biologics Report Years Considered
Figure 25. Global Self-administered Biologics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 26. Global Self-administered Biologics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 27. Global Self-administered Biologics Market Share by Region: 2024 VS 2031
Figure 28. Global Self-administered Biologics Market Share by Players in 2024
Figure 29. Global Self-administered Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 30. The Top 10 and 5 Players Market Share by Self-administered Biologics Revenue in 2024
Figure 31. North America Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. North America Self-administered Biologics Market Share by Country (2020-2031)
Figure 33. United States Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Canada Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Europe Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Europe Self-administered Biologics Market Share by Country (2020-2031)
Figure 37. Germany Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. France Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. U.K. Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Italy Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Russia Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Ireland Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Self-administered Biologics Market Share by Region (2020-2031)
Figure 45. China Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Japan Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. South Korea Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. India Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Australia & New Zealand Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Latin America Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Latin America Self-administered Biologics Market Share by Country (2020-2031)
Figure 53. Mexico Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Brazil Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Middle East & Africa Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Middle East & Africa Self-administered Biologics Market Share by Country (2020-2031)
Figure 57. Israel Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. UAE Self-administered Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 60. Novo Nordisk Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 61. Sanofi-Aventis Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 62. Eli Lilly Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 63. Tonghua Dongbao Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 64. United Laboratory Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 65. Biocon Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 66. GSK Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 68. Ganlee Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 69. Julphar Diabetes Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 70. Wockhardt Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 71. Viatris Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 72. BD Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 73. Johnson & Johnson Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 74. Amgen Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 75. Biogen Idec Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 76. Bayer Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 77. Pfizer Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 78. Roche Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 79. AbbVie Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 80. Takeda Pharmaceutical Revenue Growth Rate in Self-administered Biologics Business (2020-2025)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies